Femke I. Ehlers

Maastricht, LI 6229GT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers.

Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers.

Journal: Breast cancer research : BCR

Published: August 25, 2024

An in vitro model to monitor natural killer cell effector functions against breast cancer cells derived from human tumor tissue.

An in vitro model to monitor natural killer cell effector functions against breast cancer cells derived from human tumor tissue.

Journal: Methods in cell biology

Published: January 18, 2023

Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy.

Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: May 06, 2022

Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages.

Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages.

Journal: Cancer immunology, immunotherapy : CII

Published: February 09, 2022

Polymorphic differences within HLA-C alleles contribute to alternatively spliced transcripts lacking exon 5.

Polymorphic differences within HLA-C alleles contribute to alternatively spliced transcripts lacking exon 5.

Journal: HLA

Published: November 10, 2021

ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response.

ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response.

Journal: Cancers

Published: May 17, 2021

Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity.

Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity.

Journal: Cancers

Published: April 03, 2021

Activated Natural Killer Cells Withstand the Relatively Low Glucose Concentrations Found in the Bone Marrow of Multiple Myeloma Patients.

Activated Natural Killer Cells Withstand the Relatively Low Glucose Concentrations Found in the Bone Marrow of Multiple Myeloma Patients.

Journal: Frontiers in oncology

Published: October 29, 2020

NK cells in human visceral adipose tissue contribute to obesity-associated insulin resistance through low-grade inflammation.

NK cells in human visceral adipose tissue contribute to obesity-associated insulin resistance through low-grade inflammation.

Journal: Clinical and translational medicine

Published: September 17, 2020

Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A.

Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A.

Journal: Frontiers in immunology

Published: September 27, 2018

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment.

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment.

Journal: Frontiers in immunology

Published: March 08, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026